| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/24/2002 | EP1225223A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
| 07/24/2002 | EP1224222A2 Chemokine receptor |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224185A1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224178A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224164A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 07/24/2002 | EP1223981A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223965A2 Modulation of angiogenesis |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223948A2 Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223927A2 Use of retigabin for treating neuropathic pain |
| 07/24/2002 | EP1223926A2 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation |
| 07/24/2002 | EP1223922A2 6-methoxy-2-naphthylacetic acid prodrugs for treating inflammation |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1117356A4 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP1059934B1 Matrix protein compositions for wound healing |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0699192B1 Substituted oxazolyl compounds for the treatment of inflammation |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360568A Diacylhydrazine derivs. |
| 07/24/2002 | CN1360567A Sphingoid base devivs. and uses thereof |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/24/2002 | CN1359704A Process for preparing patch for treatment of cervicodynia |
| 07/24/2002 | CN1359703A Oral liquid for detoxicating and dispelling wind |
| 07/24/2002 | CN1359701A Aloe wine for treating injury |
| 07/24/2002 | CN1088068C Ascomycins |
| 07/24/2002 | CN1088058C Modified polyunsaturated fatty acids |
| 07/23/2002 | US6423855 Prevention lysis; oxidation resistance |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423753 Controlling angiogenesis |
| 07/23/2002 | US6423752 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity |
| 07/23/2002 | US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores |
| 07/23/2002 | US6423749 Pharmaceutical composition for injection based on paracetamol |
| 07/23/2002 | US6423747 Cosmetic and dermatological preparations with flavonoids |
| 07/23/2002 | US6423728 Heterocyclic thioamide derivatives |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423722 Antiinflammatory agents |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423702 Process for the hydroxylation of an acyclic or cyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilization of such compositions for the preparation of drugs |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423340 Gastrointestinal disorders, crohn's colitis |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2215317C Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/23/2002 | CA2087723C Treatment with flurbiprofen of pain and inflammation in mammals |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055531A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 07/18/2002 | WO2002055525A1 Retinoid agonists |
| 07/18/2002 | WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | WO2002055502A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002055087A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 07/18/2002 | WO2002055074A1 Preventives or remedies for arthritis |